Algeta: FDA Approves Xofigo (radium-223 dichloride)

News   May 17, 2013

 
Algeta: FDA Approves Xofigo (radium-223 dichloride)
 
 
 

RELATED ARTICLES

Drug Transport Gene May Explain Why Ovarian Cancer Patients React Differently to Chemotherapy

News

A gene which produces a protein that transports drugs in and out of cells may explain why some women treated with chemo have serious side effects.

READ MORE

Induced Pluripotent Stem Cells Could Serve as Cancer Vaccine

News

Induced pluripotent stem cells, or iPS cells, are a keystone of regenerative medicine. Outside the body, they can be coaxed to become many different types of cells and tissues that can help repair damage due to trauma or disease. Now, a study in mice suggests another use for iPS cells: training the immune system to attack or even prevent tumors.

READ MORE

The Inflammatory Path to Pancreatic Cancer

News

Researchers have laid out a pathway of altered gene expression that links inflammation and pancreatic cancer.

READ MORE

 

Comments | 0 ADD COMMENT

Like what you just read? You can find similar content on the communities below.

Cancer Research

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE